- Home
- GDEV vs LFCR Comparison
GDEV vs LFCR Comparison
Compare GDEV & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEV | LFCR |
|---|---|---|
| Founded | 2009 | 1986 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 308.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GDEV | LFCR |
|---|---|---|
| Price | $15.65 | $7.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 120.5K |
| Earning Date | 11-24-2025 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.98 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $412,018,000.00 | $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | $4.89 | $11.51 |
| P/E Ratio | $4.83 | ★ N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $8.60 | $4.76 |
| 52 Week High | $42.20 | $8.98 |
Technical Indicators
Market Signals| Indicator | GDEV | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 43.49 |
| Support Level | $14.47 | $8.42 |
| Resistance Level | $23.73 | $8.80 |
| Average True Range (ATR) | 1.94 | 0.37 |
| MACD | -0.22 | -0.02 |
| Stochastic Oscillator | 12.74 | 29.80 |
Price Performance
Historical ComparisonAbout GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.